MMSI logo

Merit Medical Systems, Inc. (MMSI)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Merit Medical Systems, Inc. (MMSI) trades at $69.70 with AI Score 49/100 (Weak). Merit Medical Systems, Inc. specializes in single-use medical products for interventional, diagnostic, and therapeutic procedures. Market cap: 5B, Sector: Healthcare.

Last analyzed: Feb 9, 2026
Merit Medical Systems, Inc. specializes in single-use medical products for interventional, diagnostic, and therapeutic procedures. The company operates through Cardiovascular and Endoscopy segments, serving hospitals and physicians globally.
49/100 AI Score Target $97.00 (+39.2%) MCap 5B Vol 314K

Merit Medical Systems, Inc. (MMSI) Healthcare & Pipeline Overview

CEOMartha Goldberg Aronson
Employees7400
HeadquartersSouth Jordan, UT, US
IPO Year1990

Merit Medical Systems, Inc. (MMSI) offers specialized medical devices for interventional procedures, driving growth through innovation in cardiology, radiology, and endoscopy. With a strong focus on single-use products and a global distribution network, MMSI presents a compelling investment in the expanding medical technology sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 9, 2026

Investment Thesis

Merit Medical Systems presents a notable research candidate due to its focus on high-growth interventional medical procedures. The company's strategic focus on single-use devices in cardiology, radiology, and endoscopy aligns with increasing demand for minimally invasive treatments. With a current P/E ratio of 41.27 and a solid gross margin of 48.5%, MMSI demonstrates financial stability and profitability. Key growth catalysts include expanding its product portfolio through innovation and strategic acquisitions, as well as increasing its market share in both the Cardiovascular and Endoscopy segments. The company's global distribution network and strong relationships with hospitals and physicians provide a competitive advantage. Investors may want to evaluate MMSI for its potential to deliver long-term growth and value in the expanding medical device market.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $4.89B reflects investor confidence in Merit Medical's growth potential.
  • P/E ratio of 41.27 indicates a premium valuation, reflecting expectations of future earnings growth.
  • Gross Margin of 48.5% demonstrates strong pricing power and efficient cost management.
  • Operating in the Cardiovascular and Endoscopy segments, aligning with high-growth areas in medical technology.
  • Beta of 0.61 suggests lower volatility compared to the overall market, indicating a relatively stable investment.

Competitors & Peers

Strengths

  • Diverse product portfolio across multiple medical specialties.
  • Global distribution network.
  • Focus on single-use medical devices.
  • Strong relationships with hospitals and physicians.

Weaknesses

  • High P/E ratio indicates premium valuation.
  • Dependence on third-party distributors.
  • Potential for product recalls or liability claims.
  • Exposure to currency exchange rate fluctuations.

Catalysts

  • Upcoming: New product launches in the Cardiovascular and Endoscopy segments.
  • Ongoing: Strategic acquisitions to expand product portfolio and market reach.
  • Ongoing: Increasing demand for minimally invasive procedures.
  • Ongoing: Expansion into emerging markets with high growth potential.

Risks

  • Potential: Product recalls or liability claims related to medical devices.
  • Potential: Regulatory changes and healthcare reforms impacting pricing and reimbursement.
  • Potential: Economic downturns affecting hospital budgets and capital expenditures.
  • Ongoing: Competition from established and emerging medical device companies.
  • Ongoing: Currency exchange rate fluctuations impacting international sales.

Growth Opportunities

  • Growth opportunity 1: Expanding its product portfolio through strategic acquisitions presents a significant growth opportunity for Merit Medical. By acquiring companies with complementary technologies and products, Merit Medical can broaden its offerings and enter new markets. The market for interventional medical devices is estimated at $40 billion, providing ample opportunity for growth through acquisitions. Timeline: Ongoing.
  • Growth opportunity 2: Increasing market share in the Endoscopy segment is a key growth driver for Merit Medical. The global endoscopy market is projected to reach $15 billion by 2028, driven by the increasing prevalence of gastrointestinal diseases and the demand for minimally invasive diagnostic and therapeutic procedures. Merit Medical can capitalize on this trend by expanding its product offerings and strengthening its relationships with gastroenterologists and pulmonologists. Timeline: Ongoing.
  • Growth opportunity 3: Expanding its global presence, particularly in emerging markets, offers substantial growth potential. The demand for medical devices is increasing rapidly in countries like China and India, driven by rising healthcare expenditure and improving access to healthcare services. Merit Medical can leverage its existing distribution network and establish new partnerships to penetrate these markets. Timeline: Ongoing.
  • Growth opportunity 4: Developing and commercializing innovative products for interventional oncology represents a significant growth opportunity. The market for interventional oncology devices is projected to reach $5 billion by 2027, driven by the increasing incidence of cancer and the demand for targeted therapies. Merit Medical can leverage its expertise in interventional procedures to develop innovative solutions for cancer diagnosis and treatment. Timeline: Ongoing.
  • Growth opportunity 5: Enhancing its custom procedural solutions business, which includes critical care products, disinfection protection systems, and manifold kits, offers a stable and recurring revenue stream. The market for custom procedure trays is estimated at $10 billion, driven by the increasing demand for standardized and efficient medical procedures. Merit Medical can strengthen its position in this market by expanding its product offerings and providing customized solutions to hospitals and physicians. Timeline: Ongoing.

Opportunities

  • Expanding product portfolio through strategic acquisitions.
  • Increasing market share in emerging markets.
  • Developing innovative products for interventional oncology.
  • Strengthening its custom procedural solutions business.

Threats

  • Increasing competition from established and emerging medical device companies.
  • Regulatory changes and healthcare reforms.
  • Economic downturns affecting hospital budgets.
  • Technological obsolescence.

Competitive Advantages

  • Specialized product portfolio focused on interventional procedures.
  • Strong relationships with hospitals and physicians.
  • Global distribution network.
  • Expertise in single-use medical device manufacturing.

About MMSI

Merit Medical Systems, Inc., founded in 1987 and headquartered in South Jordan, Utah, is a global manufacturer and marketer of single-use medical devices. The company focuses on interventional, diagnostic, and therapeutic procedures, primarily serving the cardiology, radiology, oncology, critical care, and endoscopy markets. Merit Medical operates through two segments: Cardiovascular and Endoscopy. The Cardiovascular segment provides products for peripheral and cardiac interventions, including access, angiography, electrophysiology, fluid management, and hemostasis devices. The Endoscopy segment offers products for pulmonary and gastroenterology procedures, including stents, dilation balloons, and accessories. Merit Medical's products are sold to hospitals, physicians, and original equipment manufacturers through a direct sales force, distributors, and custom procedure tray manufacturers. The company's focus on innovation and strategic acquisitions has allowed it to expand its product portfolio and geographic reach, establishing a strong position in the medical device industry. With a commitment to improving patient outcomes and providing cost-effective solutions, Merit Medical continues to drive growth and create value for its stakeholders. The company's diverse product offerings and global presence contribute to its resilience and long-term growth potential.

What They Do

  • Designs, develops, and manufactures single-use medical products.
  • Offers products for interventional, diagnostic, and therapeutic procedures.
  • Focuses primarily on cardiology, radiology, oncology, critical care, and endoscopy.
  • Provides peripheral intervention products for treating diseases in vessels and organs.
  • Offers cardiac intervention products for various heart conditions.
  • Supplies pulmonary products, including stents and dilation balloons.
  • Provides gastroenterology products and accessories.
  • Offers custom procedural solutions, including critical care products and disinfection systems.

Business Model

  • Develops and manufactures single-use medical devices.
  • Sells products directly to hospitals and physicians through a direct sales force.
  • Utilizes distributors and OEM partners to expand market reach.
  • Offers custom procedure trays to meet specific customer needs.

Industry Context

Merit Medical Systems operates within the medical device industry, which is characterized by continuous innovation and increasing demand for minimally invasive procedures. The global medical device market is projected to reach $600 billion by 2025, driven by an aging population and advancements in medical technology. The competitive landscape includes established players and emerging companies focused on specialized segments. Merit Medical's focus on single-use devices and its presence in both the Cardiovascular and Endoscopy markets position it favorably to capitalize on these trends. The company's ability to develop and commercialize innovative products will be crucial for maintaining its competitive edge and capturing market share.

Key Customers

  • Hospitals and alternate site-based physicians.
  • Technicians and nurses.
  • Original equipment manufacturer partners.
  • Custom procedure tray manufacturers.
AI Confidence: 72% Updated: Feb 9, 2026

Financials

Chart & Info

Merit Medical Systems, Inc. (MMSI) stock price: $69.70 (+1.59, +2.33%)

Latest News

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MMSI.

Price Targets

Consensus target: $97.00

MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates MMSI's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Latest Merit Medical Systems, Inc. Analysis

MMSI Healthcare Stock FAQ

What does Merit Medical Systems, Inc. do?

Merit Medical Systems, Inc. is a global manufacturer and marketer of single-use medical devices used in interventional, diagnostic, and therapeutic procedures. The company operates through two segments, Cardiovascular and Endoscopy, providing a range of products for cardiology, radiology, oncology, critical care, and endoscopy. These products are sold to hospitals, physicians, and original equipment manufacturers through a direct sales force, distributors, and custom procedure tray manufacturers. Merit Medical focuses on developing innovative and cost-effective solutions to improve patient outcomes and drive growth in the medical device industry.

Is MMSI stock worth researching?

MMSI stock presents a mixed picture for potential investors. The company's strong market position in interventional medical devices and its focus on high-growth segments like cardiology and endoscopy are positive indicators. However, the high P/E ratio of 41.27 suggests a premium valuation, and investors should carefully consider whether the company's growth prospects justify this valuation. Key factors to consider include the company's ability to execute its growth strategies, maintain its competitive edge, and manage its financial performance. A balanced analysis of these factors is essential before making an investment decision.

What are the main risks for MMSI?

Merit Medical Systems faces several key risks, including potential product recalls or liability claims related to its medical devices. Regulatory changes and healthcare reforms could impact pricing and reimbursement, affecting the company's revenue and profitability. Economic downturns could reduce hospital budgets and capital expenditures, impacting demand for Merit Medical's products. The company also faces increasing competition from established and emerging medical device companies. Currency exchange rate fluctuations could negatively impact international sales and earnings. Effective risk management is crucial for Merit Medical to mitigate these challenges and sustain its growth.

What are the key factors to evaluate for MMSI?

Merit Medical Systems, Inc. (MMSI) currently holds an AI score of 49/100, indicating low score. The stock trades at a P/E of 32.2x, near the S&P 500 average (~20-25x). Analysts target $97.00 (+39% from $69.70). Key strength: Diverse product portfolio across multiple medical specialties.. Primary risk to monitor: Potential: Product recalls or liability claims related to medical devices.. This is not financial advice.

How frequently does MMSI data refresh on this page?

MMSI prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven MMSI's recent stock price performance?

Recent price movement in Merit Medical Systems, Inc. (MMSI) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $97.00 implies 39% upside from here. Notable catalyst: Diverse product portfolio across multiple medical specialties.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider MMSI overvalued or undervalued right now?

Determining whether Merit Medical Systems, Inc. (MMSI) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 32.2. Analysts target $97.00 (+39% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying MMSI?

Before investing in Merit Medical Systems, Inc. (MMSI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Stock data pending update. Financial metrics based on available data as of 2026-02-09. Future performance is subject to market conditions and company-specific factors.
Data Sources

Popular Stocks